Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00603551 · ClinicalTrials.gov registry record
Screening of Bone Mineral Density in Women Who Have Received Chemotherapy
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 106
- Enrollment target
NCT00603551 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 106 participants.
The verdict
NCT00603551 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 106 participants
- Enrollment target
Study Summary
The hypothesis is that postmenopausal women who have received chemotherapy have a greater bone loss than the same age controls. The aim of this study is to obtain baseline bone mineral density (BMD) data on women with breast and gynecological cancers who have received chemotherapy. By comparing the Z scores of postmenopausal women who have received chemotherapy with age matched controls this hypothesis can be evaluated. Another goal of the study is to compare the T-score of a Heel Bone Density Scan to the T-score of the DXA Scan to see if there is a good correlation between peripheral and DXA scores.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00603551
The ClinicalTrials.gov registry entry for NCT00603551 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00603551 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00603551 about?
NCT00603551 is a clinical study titled "Screening of Bone Mineral Density in Women Who Have Received Chemotherapy". The hypothesis is that postmenopausal women who have received chemotherapy have a greater bone loss than the same age controls. The aim of this study is to obtain baseline bone mineral density (BMD) data on women with breast and gynecological cancers who have received chemotherapy. By comparing the ...
What is the current status of trial NCT00603551?
This trial is currently completed. The enrollment target is 106 participants. The study started on 2006-11. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00603551?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.